Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Long-Term Deferred Tax (2016)

Historic Long-Term Deferred Tax for Myriad Genetics (MYGN) over the last 7 years, with Q2 2016 value amounting to $12.7 million.

  • Myriad Genetics' Long-Term Deferred Tax changed N/A to $12.7 million in Q2 2016 from the same period last year, while for Jun 2016 it was $12.7 million, marking a year-over-year change of. This contributed to the annual value of $12.7 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Myriad Genetics reported Long-Term Deferred Tax of $12.7 million as of Q2 2016.
  • Over the past 5 years, Myriad Genetics' Long-Term Deferred Tax peaked at $30.6 million during Q2 2012, and registered a low of $407000.0 during Q1 2015.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $27.0 million (2012), whereas its average is $21.3 million.
  • In the last 5 years, Myriad Genetics' Long-Term Deferred Tax soared by 2193.17% in 2013 and then plummeted by 8882.37% in 2014.
  • Over the past 5 years, Myriad Genetics' Long-Term Deferred Tax (Quarter) stood at $24.6 million in 2012, then rose by 21.93% to $30.0 million in 2013, then crashed by 89.33% to $3.2 million in 2014, then soared by 321.88% to $13.5 million in 2015, then decreased by 5.93% to $12.7 million in 2016.
  • Its Long-Term Deferred Tax was $12.7 million in Q2 2016, compared to $13.5 million in Q4 2015 and $407000.0 in Q1 2015.